{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:03:31Z","timestamp":1791263011120,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1136\/annrheumdis-2012-201887","type":"journal-article","created":{"date-parts":[[2012,8,22]],"date-time":"2012-08-22T02:13:32Z","timestamp":1345601612000},"page":"754-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-\u03b1 on endothelial cells"],"prefix":"10.1016","volume":"72","author":[{"given":"Arnaud","family":"Hot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Lavocat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanina","family":"Lenief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Miossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2012-201887_bib1","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.2174\/138161210794455120","article-title":"The antiplatelet and antithrombotic actions of statins","volume":"16","author":"Mitsios","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1136\/annrheumdis-2012-201887_bib2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.CIR.0000138743.09012.93","article-title":"Antioxidant effects of statins via s-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins","volume":"110","author":"Haendeler","year":"2004","journal-title":"Circulation"},{"key":"10.1136\/annrheumdis-2012-201887_bib3","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archinternmed.2010.182","article-title":"Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants","volume":"170","author":"Ray","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1136\/annrheumdis-2012-201887_bib4","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(09)60447-5","article-title":"Reduction in c-reactive protein and ldl cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the Jupiter trial","volume":"373","author":"Ridker","year":"2009","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2012-201887_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-2004-869599","article-title":"Anti-inflammatory properties of statins","volume":"4","author":"Steffens","year":"2004","journal-title":"Semin Vasc Med"},{"key":"10.1136\/annrheumdis-2012-201887_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/11315710-000000000-00000","article-title":"Non-atheroprotective effects of statins: a systematic review","volume":"9","author":"Beri","year":"2009","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1136\/annrheumdis-2012-201887_bib7","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.healun.2004.08.014","article-title":"Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up","volume":"24","author":"Stojanovic","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1136\/annrheumdis-2012-201887_bib8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1586\/14737175.8.5.827","article-title":"Potential therapeutic role of statins in neurological disorders","volume":"8","author":"Bifulco","year":"2008","journal-title":"Expert Rev Neurother"},{"key":"10.1136\/annrheumdis-2012-201887_bib9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper t cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2012-201887_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/path.2667","article-title":"Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques","volume":"220","author":"de Boer","year":"2010","journal-title":"J Pathol"},{"key":"10.1136\/annrheumdis-2012-201887_bib11","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.4049\/jimmunol.0901126","article-title":"Inhibition of il-17a attenuates atherosclerotic lesion development in apoe-deficient mice","volume":"183","author":"Erbel","year":"2009","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2012-201887_bib12","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/ard.2010.148031","article-title":"Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis","volume":"70","author":"Marder","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201887_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jacc.2011.10.863","article-title":"Interleukin-17a contributes to myocardial ischemia\/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration","volume":"59","author":"Liao","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1136\/annrheumdis-2012-201887_bib14","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2011-200468","article-title":"Combination of il-17 and tnfalpha induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells","volume":"71","author":"Hot","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201887_bib15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bbrc.2011.04.080","article-title":"Il-17a increases adp-induced platelet aggregation","volume":"408","author":"Maione","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/annrheumdis-2012-201887_bib16","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/hq0801.094222","article-title":"In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products","volume":"21","author":"Diomede","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1136\/annrheumdis-2012-201887_bib17","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.4049\/jimmunol.181.5.3524","article-title":"Statins induce regulatory t cell recruitment via a ccl1 dependent pathway","volume":"181","author":"Mira","year":"2008","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2012-201887_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12272-001-1141-2","article-title":"Inhibitory effect of simvastatin on the tnf-alpha- and angiotensin ii-induced monocyte adhesion to endothelial cells is mediated through the suppression of geranylgeranyl isoprenoid-dependent ros generation","volume":"31","author":"Park","year":"2008","journal-title":"Arch Pharm Res"},{"key":"10.1136\/annrheumdis-2012-201887_bib19","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/01.CIR.0000015465.73933.3B","article-title":"Statin prevents tissue factor expression in human endothelial cells: role of rho\/rho-kinase and akt pathways","volume":"105","author":"Eto","year":"2002","journal-title":"Circulation"},{"key":"10.1136\/annrheumdis-2012-201887_bib20","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.4049\/jimmunol.180.10.6988","article-title":"Simvastatin inhibits il-17 secretion by targeting multiple il-17-regulatory cytokines and by inhibiting the expression of il-17 transcription factor rorc in cd4+ lymphocytes","volume":"180","author":"Zhang","year":"2008","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2012-201887_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4049\/jimmunol.161.1.409","article-title":"Enhancing effect of il-17 on il-1-induced il-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by th2 cytokines","volume":"161","author":"Chabaud","year":"1998","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2012-201887_bib22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sj.bjp.0704454","article-title":"Hmg coa reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins","volume":"135","author":"Wiesbauer","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1136\/annrheumdis-2012-201887_bib23","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.4049\/jimmunol.0801967","article-title":"Genome-wide comparison between il-17a- and il-17f-induced effects in human rheumatoid arthritis synoviocytes","volume":"182","author":"Zrioual","year":"2009","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2012-201887_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"Il-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J Exp Med"},{"key":"10.1136\/annrheumdis-2012-201887_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1084\/jem.185.1.153","article-title":"Loss of atp diphosphohydrolase activity with endothelial cell activation","volume":"185","author":"Robson","year":"1997","journal-title":"J Exp Med"},{"key":"10.1136\/annrheumdis-2012-201887_bib26","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1074\/jbc.273.5.2792","article-title":"Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor","volume":"273","author":"Bajzar","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1136\/annrheumdis-2012-201887_bib27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrrheum.2009.219","article-title":"Vascular effects of biologic agents in ra and spondyloarthropathies","volume":"5","author":"Szekanecz","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201887_bib28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cytogfr.2010.10.003","article-title":"Interleukin 17 in vascular inflammation","volume":"21","author":"von Vietinghoff","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1136\/annrheumdis-2012-201887_bib29","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.CIR.101.15.1760","article-title":"Hydroxymethylglutaryl coenzyme a reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with chlamydia pneumoniae","volume":"101","author":"Kothe","year":"2000","journal-title":"Circulation"},{"key":"10.1136\/annrheumdis-2012-201887_bib30","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/01.ATV.0000190672.36490.7b","article-title":"Expression of fractalkine (cx3cl1) and its receptor, cx3cr1, is elevated in coronary artery disease and is reduced during statin therapy","volume":"25","author":"Damas","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1136\/annrheumdis-2012-201887_bib31","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1161\/CIRCULATIONAHA.107.743872","article-title":"Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in ccr2\u2212\/\u2212 mice: evidence for independent chemokine functions in atherogenesis","volume":"117","author":"Saederup","year":"2008","journal-title":"Circulation"},{"key":"10.1136\/annrheumdis-2012-201887_bib32","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.4049\/jimmunol.165.5.2712","article-title":"Simvastatin modulates cytokine-mediated endothelial cell adhesion molecule induction: involvement of an inhibitory g protein","volume":"165","author":"Sadeghi","year":"2000","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2012-201887_bib33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/CIRCRESAHA.111.242578","article-title":"Genetic deletion of chemokine receptor ccr6 decreases atherogenesis in apoe-deficient mice","volume":"109","author":"Wan","year":"2011","journal-title":"Circ Res"},{"key":"10.1136\/annrheumdis-2012-201887_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bcp.2006.09.007","article-title":"Statins decrease tnf-alpha-induced osteoprotegerin production by endothelial cells and smooth muscle cells in vitro","volume":"73","author":"Ben-Tal Cohen","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1136\/annrheumdis-2012-201887_bib35","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the british society for rheumatology biologics register","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201887_bib36","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/01.ATV.0000018305.95943.F7","article-title":"Reversal of thrombin-induced deactivation of cd39\/atpdase in endothelial cells by hmg-coa reductase inhibition: effects on rho-gtpase and adenosine nucleotide metabolism","volume":"22","author":"Kaneider","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1136\/annrheumdis-2012-201887_bib37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.yjmcc.2007.05.006","article-title":"Simvastatin inhibits tnfalpha-induced invasion of human cardiac myofibroblasts via both mmp-9-dependent and -independent mechanisms","volume":"43","author":"Turner","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1136\/annrheumdis-2012-201887_bib38","first-page":"1317","article-title":"Simvastatin and lovastatin inhibit breast cell invasion induced by h-ras","volume":"21","author":"Kang","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1136\/annrheumdis-2012-201887_bib39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrrheum.2009.29","article-title":"Management of cardiovascular disease risk in chronic inflammatory disorders","volume":"5","author":"Kaplan","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201887_bib40","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of atorvastatin in rheumatoid arthritis (tara): double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2012-201887_bib41","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/ard.2007.086157","article-title":"Infliximab improves vascular stiffness in patients with rheumatoid arthritis","volume":"68","author":"Wong","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201887_bib42","doi-asserted-by":"crossref","first-page":"R178","DOI":"10.1186\/ar2867","article-title":"Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis","volume":"11","author":"Mulleman","year":"2009","journal-title":"Arthritis Res Ther"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724215375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724215375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2012-201887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:35:44Z","timestamp":1737250544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724215375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0003496724215375"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201887","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-\u03b1 on endothelial cells","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 \u00a9 2013 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}